glp-1 drugs pharmaceutical companies news 2025 Market Trends and Global Forecasts Report 2025: A GLP-1 2.0: Where the Next
Description
As use continues to grow, emergency physicians will encounter these medications more frequently across a broader patient population
When a novel therapy shows real promise of helping patients and garnering FDA approval, it is not long before other companies launch their own efforts
Other Drugs 4.6.1
Ozempic is a brand-name drug for semaglutide approved for the treatment of type 2 diabetes
Do not buy GLP-1 drugs from unregulated online marketplaces
Roughly a quarter of the weight lost tends to be lean mass, with a range of about 15% to 40% across studies (Karakasis 2024)
